Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Feb 16, 2024; 12(5): 931-941
Published online Feb 16, 2024. doi: 10.12998/wjcc.v12.i5.931
Table 1 Correlation between glucose transport protein 1 expression and clinicopathological parameters
GLUT-1 (center)
P value
GLUT-1 (periphery)
P value

(-) (n = 83)
(+) (n = 86)
(-) (n = 78)
(+) (n = 91)
Age (yr ± SD)64.0 ± 11.464.7 ± 12.60.74064.0 ± 11.664.7 ± 12.40.718
Sex
Male52540.98551550.507
Female31322736
Tumor size (mean ± SD)4.9 ± 1.85.2 ± 2.00.2775.1 ± 1.75.1 ± 2.10.932
T stage
T1, 21670.03511120.836
T3, 467796779
N stage
N051480.45748510.47
N1-232383040
AJCC stage
I, II49480.67247500.486
III, IV34383141
Lymphatic invasion
Negative70720.91364780.517
Positive13141413
Perineural invasion
Negative66730.36168710.12
Positive17131020
Blood glucose level (mean ± SD)110.5 ± 36.2111.6 ± 25.80.818112.4 ± 38.8109.9 ± 23.20.612
SUVmax of primary tumor (mean ± SD)12.3 ± 5.916.1 ± 7.4<0.00113.0 ± 6.415.3 ± 7.30.030
SUVmax of lymph node (mean ± SD)1.04 ± 2.62.15 ± 3.10.0120.99 ± 2.62.13 ± 3.00.010